Search research articles
Contact Us
Filters
Showing results (611-620 of 653) with videos related to
Page
of 66
Sort By:
Medecine Tropicale : Revue Du Corps De Sante Colonial
|
January 1, 1981
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]
M Germain, M Cornet, J Mouchet, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2017
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection
Stefan Wirth, Philip Rosenthal, Regino P Gonzalez-Peralta, et al.
Physical Review Letters
|
January 22, 2021
Energy-Spread Preservation and High Efficiency in a Plasma-Wakefield Accelerator
C A Lindstrøm, J M Garland, S Schröder, et al.
Nano-Micro Letters
|
June 18, 2024
Polymer Fiber Rigid Network with High Glass Transition Temperature Reinforces Stability of Organic Photovoltaics
Qiao Zhou, Cenqi Yan, Hongxiang Li, et al.
Frontiers in Physiology
|
July 12, 2023
Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site
S E Hamm, C Yuan, L F McQueen, et al.
Nature Communications
|
February 11, 2026
Bright electron bunches from a plasma-wakefield accelerator with a steep density down-ramp
J C Wood, L Boulton, J Beinortaitė, et al.
Journal of Medical Virology
|
November 12, 2024
Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in Brazil
Leidiane B Ribeiro, Luciana A Reche, Ana C de Seixas Santos Nastri, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 27, 2013
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C
Jean P Molleston, William Mellman, Michael R Narkewicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Journal of Pharmaceutical Sciences
|
May 4, 2023
Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report
M Mehta, J E Polli, P Seo, et al.
Page
of 66
Search research articles
Search
Showing results (611-620 of 653) with videos related to
Sort By:
Page
of 66
Medecine Tropicale : Revue Du Corps De Sante Colonial
|
January 1, 1981
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]
M Germain, M Cornet, J Mouchet, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2017
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection
Stefan Wirth, Philip Rosenthal, Regino P Gonzalez-Peralta, et al.
Physical Review Letters
|
January 22, 2021
Energy-Spread Preservation and High Efficiency in a Plasma-Wakefield Accelerator
C A Lindstrøm, J M Garland, S Schröder, et al.
Nano-Micro Letters
|
June 18, 2024
Polymer Fiber Rigid Network with High Glass Transition Temperature Reinforces Stability of Organic Photovoltaics
Qiao Zhou, Cenqi Yan, Hongxiang Li, et al.
Frontiers in Physiology
|
July 12, 2023
Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site
S E Hamm, C Yuan, L F McQueen, et al.
Nature Communications
|
February 11, 2026
Bright electron bunches from a plasma-wakefield accelerator with a steep density down-ramp
J C Wood, L Boulton, J Beinortaitė, et al.
Journal of Medical Virology
|
November 12, 2024
Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in Brazil
Leidiane B Ribeiro, Luciana A Reche, Ana C de Seixas Santos Nastri, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 27, 2013
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C
Jean P Molleston, William Mellman, Michael R Narkewicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Journal of Pharmaceutical Sciences
|
May 4, 2023
Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report
M Mehta, J E Polli, P Seo, et al.
Page
of 66